France Ultrasound Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026 - 2031)

According to Mordor Intelligence, the France ultrasound devices market size is expected to grow from USD 418.82 million in 2025 to USD 438.46 million in 2026 and is forecast to reach USD 551.45 million by 2031 at 4.69% CAGR over 2026-2031.

This report is Segmented by Application (Anesthesiology, Cardiology, Gynecology/Obstetrics, Musculoskeletal, Radiology, and More), Technology (2D Ultrasound Imaging, 3D & 4D Ultrasound Imaging, Doppler Imaging, and More), Portability (Stationary Systems, and More), and End User (Hospitals, Diagnostic Centers, and More). The Market Forecasts are Provided in Terms of Value (USD).

France Ultrasound Devices Market Trends and Insights

Aging Population & Chronic Disease Burden

The share of residents aged 65 and above reached 21.8% in 2025, and higher life expectancy has pushed cardiovascular and musculoskeletal case loads that rely on non-ionizing imaging. Echocardiography volumes continue to grow in community clinics as general practitioners incorporate ultrasound into chronic-care pathways to limit hospital readmissions. Peripheral joint evaluation needs also expand because the same demographic supports a rise in osteoarthritis interventions. Although physician numbers rose 1.7% year-on-year, specialist appointments remain scarce outside metropolitan areas, amplifying ultrasound's value as a gatekeeper modality in primary care. This demographic reality anchors a long-term driver that offsets intermittent budget tightening.

Rapid Adoption of Point-of-Care Ultrasound in Emergency Departments

French hospitals increased emergency-department (ED) ultrasound availability, validating bedside imaging as a clinical standard. Prospective studies show point-of-care ultrasound (POCUS) alters diagnostic decisions in 82% of ED visits and therapeutic plans in 47% of cases, building a compelling evidence base for continued procurement. The national emergency-medicine society has set competency frameworks that mandate supervised scanning milestones, ensuring uniform skill development across regions. Field research by French defense forces underscores the technique's adaptability, with untrained nurses reporting 96% willingness to pursue instruction for combat support. Together, these findings explain why the France ultrasound devices market continues to pivot toward compact, battery-operated scanners that meet tight ED turnaround times.

EU MDR Re-Certification Costs & Delays

Manufacturers contend with expanded technical-file audits, post-market surveillance, and rising notified-body fees as deadlines move toward 2028. The burden is acute for smaller suppliers that lack dedicated regulatory staff, raising the risk of product withdrawal and tightening hospital supply options. French GMED's queue times elongate purchasing cycles, driving hospitals to extend asset life instead of refreshing fleets, which suppresses near-term market uptake.

Other drivers and restraints analyzed in the detailed report include:

1. Continuous Upgrades in 2D/3D/4D & AI-Enabled Imaging
2. Government Push to Reduce Radiation Exposure
3. High Capital & Maintenance Costs of Advanced Systems

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Critical care applications grew at a 6.02% CAGR, a pace that positions them as the most dynamic slice of the France ultrasound devices market. Intensivists increasingly favor handheld scanners for bedside evaluations that shorten average sepsis diagnosis time by 18 minutes. At the same time, radiology retains 35.05% of 2025 revenue because it remains the central imaging gatekeeper in large academic centers. Cardiology growth aligns with AI-enhanced fetal and adult echo protocols introduced after Samsung's Sonio buyout. Conversely, the gynecology/obstetrics sub-segment faces headwinds from the decline to 663,000 births in 2024. Musculoskeletal demand rises on the back of arthroplasty volume growth, and vascular assessments exploit HIFU guidance for chronic venous disease therapy. Together these dynamics maintain a balanced demand structure that underpins a diverse end-user base.

Critical care's larger addressable patient turnover, amplified by ED POCUS programs, ensures persistent capital flow into cart-based and portable platforms. Hospitals invest in AI-driven workflow tools that auto-measure ejection fraction, reducing exam variability and catering to the chronic heart-failure cohort.

HIFU is projected to grow 5.56% annually, benefiting from prostate-cancer studies reporting 90% salvage-free survival at three years. While 3D & 4D imaging maintained a 39.41% share in 2025, catheter-based procedures increasingly incorporate 4D fusion guidance. Open-architecture scanners capable of software upgrades allow hospitals to avoid complete console replacement, sustaining loyalty to incumbent brands.

The France ultrasound devices market share for 3D & 4D systems is expected to remain dominant through 2031, yet HIFU's procedural reimbursement expansions hint at accelerating penetration. The Focused Ultrasound Foundation logs 171 active indications globally, with oncology, vascular, and aesthetics driving clinical pipeline diversification. That breadth of therapeutic application secures downstream demand for disposables and service contracts long after equipment installation.

Complete Report Scope:

• By Application
  • Anesthesiology
  • Cardiology
  • Gynecology / Obstetrics
  • Musculoskeletal
  • Radiology
  • Critical Care
  • Urology
  • Vascular
  • Other Applications
• By Technology
  • 2D Ultrasound Imaging
  • 3D & 4D Ultrasound Imaging
  • Doppler Imaging
  • High-Intensity Focused Ultrasound
  • Other Technologies
• By Portability
  • Stationary Systems
  • Portable Cart-based Systems
  • Hand-held / Pocket Devices
• By End User
  • Hospitals
  • Diagnostic Centers
  • Ambulatory Surgical Centers
  • Other End Users

List of Companies Covered in this Report:

1. Canon
2. GE Healthcare
3. Koninklijke Philips
4. Siemens Healthineers
5. Mindray
6. FUJIFILM
7. Samsung Group
8. Esaote
9. SonoScape Medical Corp.
10. Hologic
11. Hitachi
12. Alpinion Medical Systems
13. Butterfly Network Inc.
14. Supersonic Imagine SA
15. Analogic
16. Terason Corporation
17. Clarius Mobile Health
18. Fujifilm Sonosite Inc.
19. Shenzhen Lifotronic Technology

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support